Free Trial

Inhibikase Therapeutics (IKT) Income Statement & Balance Sheet

$1.81
-0.02 (-1.09%)
(As of 05/24/2024 ET)

Inhibikase Therapeutics Income Statement, Balance Sheet and Cash Flow Statement


This page (NYSE:IKT) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners